Robust Estimation and Inference in Hybrid Controlled Trials for Binary Outcomes: A Case Study on Non-Small Cell Lung Cancer
Publication
, Preprint
Liu, J; Zhu, K; Yang, S; Wang, X
April 30, 2025
Duke Scholars
Publication Date
April 30, 2025
Citation
APA
Chicago
ICMJE
MLA
NLM
Liu, J., Zhu, K., Yang, S., & Wang, X. (2025). Robust Estimation and Inference in Hybrid Controlled Trials for Binary
Outcomes: A Case Study on Non-Small Cell Lung Cancer.
Liu, Jiajun, Ke Zhu, Shu Yang, and Xiaofei Wang. “Robust Estimation and Inference in Hybrid Controlled Trials for Binary
Outcomes: A Case Study on Non-Small Cell Lung Cancer,” April 30, 2025.
Liu J, Zhu K, Yang S, Wang X. Robust Estimation and Inference in Hybrid Controlled Trials for Binary
Outcomes: A Case Study on Non-Small Cell Lung Cancer. 2025.
Liu, Jiajun, et al. Robust Estimation and Inference in Hybrid Controlled Trials for Binary
Outcomes: A Case Study on Non-Small Cell Lung Cancer. 30 Apr. 2025.
Liu J, Zhu K, Yang S, Wang X. Robust Estimation and Inference in Hybrid Controlled Trials for Binary
Outcomes: A Case Study on Non-Small Cell Lung Cancer. 2025.
Publication Date
April 30, 2025